---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-082813"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2022-07-26T23:59:59+00:00"
generated_at: "2026-06-24T08:33:20.305314+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NWBO eliminates Series A/B Preferred, creates Series C Preferred (10M shares)

## Summary
- Filed Certificate of Elimination for Series A and B Preferred Stock on July 20, 2022; no shares outstanding.
- Created Series C Preferred Stock with 10M shares, $0.001 par value, rights and preferences established.
- Series C created from authorized but unissued preferred shares; effective July 20, 2022.

## SEC filing metadata
- accession: 0001104659-22-082813
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2022-07-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465922082813/0001104659-22-082813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465922082813/tm2221829d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-082813
- JSON: https://secwatch.observer/filing/0001104659-22-082813.json
- Plain text: https://secwatch.observer/filing/0001104659-22-082813.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.